norethindrone and tibolone

norethindrone has been researched along with tibolone in 67 studies

Research

Studies (67)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (2.99)	18.7374
1990's	7 (10.45)	18.2507
2000's	46 (68.66)	29.6817
2010's	12 (17.91)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kollman, PA; Lee, DL; Marsh, FJ; Wolff, ME	1
Campanini, D; Facchinetti, F; Genazzani, AR; Grasso, A; Petraglia, F; Volpe, A	1
Haverkorn, MJ; Meuwissen, JH; Wiegerinck, MA	1
Schreiber, V; Stĕpán, JJ	1
Hammar, M; Nathorst-Böös, J	1
Christau, S; Garre, K; Hammar, M; Nathorst-Böös, J; Rud, T	1
Laird, SM; Lee, S; Li, TC; Okon, MA	1
Akkad, A; Al-Azzawi, F; Habiba, M; Mason, T; Wahab, M	1
Coelingh Bennink, HJ; Dören, M; Holzgreve, W; Rübig, A	3
Agrawal, R; Conway, GS; Ginsburg, J; Jacobs, HS; Payne, NN; Prelevic, G	1
Altkemper, R; Coelingh Bennink, HJ; Helmond, FA; Kwee, B; Winkler, UH	1
Albertazzi, P; Barbolini, C; Di Micco, R; Natale, V; Teglio, L	1
Guest, JF; Plumb, JM	1
Bilgen, I; Bilgin, O; Coşan Terek, M; Memiş, A; Ozşener, S; Oztekin, K; Sendağ, F	1
Mueck, AO; Seeger, H; Wallwiener, D	1
Azavedo, E; Barkfeldt, J; Christow, A; Kersemaekers, W; Lundström, E; Mol-Arts, M; Söderqvist, G; Svane, G; von Schoultz, B	1
Benhamou, CL; Fechtenbaum, J; Loiseau-Peres, S; Pelissier, C; Roux, C	1
Lippert, C; Mueck, AO; Seeger, H; Wallwiener, D	1
Karakus, C; Simsek, T; Trak, B	1
Benhamou, CL; Garnero, P; Jamin, C; Pelissier, C; Roux, C	1
Jamin, C; Madelenat, P; Poncelet, C	1
Bonnar, J; Joyce, M; Norris, LA; O'Keeffe, N; Sheppard, BL	1
Alpaslan, M; Fenkci, S; Fenkci, V; Onrat, E; Yilmazer, M	1
Arabi, A; Benhamou, CL; Garnero, P; Pelissier, C; Porcher, R; Roux, C	1
Aban, M; Atiş, S; Camdeviren, H; Kiliç, F; Pata, C; Pata, O; Tok, E; Utku Oz, A; Yazici, G	1
Alatas, E; Demir, S; Kaleli, B; Yildirim, B	1
Carlström, K; Christow, A; Conner, P; Kersemaekers, W; Mol-Arts, M; Skoog, L; Söderqvist, G; Tani, E; von Schoultz, B	1
Christodoulakos, GE; Creatsas, GC; Kouskouni, EE; Lambrinoudaki, IV; Panoulis, CP; Papadias, CA	1
Aytan, H; Kelekci, S; Mollamahmutoglu, L; Oguz, S; Sargin, A; Tapisiz, OL	1
Botsis, D; Caramalis, G; Christodoulakos, G; Creatsas, G; Lambrinoudaki, I; Panoulis, C; Rizos, D; Sioulas, V	1
Azavedo, E; Carlström, K; Hofling, M; Kloosterboer, H; Svane, G; Von Schoultz, B	1
Griva, BL; Luca, LA; Morceli, J; Moriguchi, SM; Nahas, EA; Nahas-Neto, J; Traiman, P; Uemura, G	1
Bernardi, F; Casarosa, E; Gabbanini, M; Genazzani, AD; Genazzani, AR; Luisi, M; Palumbo, M; Picciarelli, G; Pieri, M; Pluchino, N	1
Bozkaya, H; Okumuş, B; Osmanağaoğlu, MA; Osmanağaoğlu, S; Osmanağaoğlu, T	1
Franke, HR; Vermes, I; Werner, HM	1
Parsons, MF; Purohit, A; Raobaikady, B; Reed, MJ	2
Andersen, TO; Eilertsen, AL; Qvigstad, E; Sandset, PM; Sandvik, L	1
Arangino, S; Cagnacci, A; Cannoletta, M; Pirillo, D; Renzi, A; Volpe, A	1
Christodoulakos, GE; Creatsas, GC; Economou, EV; Kouskouni, EE; Lambrinoudaki, IV; Panoulis, CP; Papadias, C; Vitoratos, N; Vlachou, SA	1
Andersen, TO; Eilertsen, AL; Mowinckel, MC; Qvigstad, E; Sandset, PM; Sandvik, L	1
Christodoulakos, GE; Creatsas, GC; Fexi, P; Koundi, KL; Lambrinoudaki, IV; Sakkas, PN; Soldatos, CR; Spyropoulou, A; Zervas, IM	1
Eilertsen, AL; Hemker, HC; Liestøl, S; Mowinckel, MC; Sandset, PM	1
Kloosterboer, HJ; Mueck, AO; Seeger, H; Studen, M; Wallwiener, D	1
Kuhl, H; Wiegratz, I	1
Alexandrou, AP; Bastounis, E; Bramis, J; Christodoulakos, GE; Creatsas, GC; Dalamanga, A; Keramaris, NC; Lambrinoudaki, IV	1
Franke, HR; Hammar, ML; Nijland, EA; Pornel, B; van de Weijer, P; von Mauw, EM	1
Alexandrou, AP; Christodoulakos, GE; Creatsas, GC; Economou, EV; Kouskouni, EE; Lambrinoudaki, IV; Panoulis, CP; Vlachou, SA	1
Davis, SR; Helmond, FA; Mulder, RJ; Nathorst-Boös, J; Nijland, EA; Norman, RJ; Palacios, S; Van Lunsen, RH; Weijmar Schultz, WC	1
Eilertsen, AL; Karssemeijer, N; Qvigstad, E; Sandset, PM; Skaane, P	1
Bruce, D; Frick, A; Robinson, J; Rymer, J; Ylikorkala, O	1
Birkhaeuser, MH; Davis, S; Mulder, RJ; Nathorst-Böös, J; Nijland, EA; Palacios, S; Schultz, WC; Stathopoulos, VM; van de Weijer, PW; von Mauw, E	1
Bjørndal, H; Ma, H; Stuedal, A; Ursin, G	1
Alexandrou, A; Christodoulakos, G; Creatsa, M; Grigoriou, O; Kaparos, G; Karaflou, M; Kouskouni, E; Lambrinoudaki, I; Logothetis, E; Panoulis, C	1
De Geyter, C; De Napoli, G; de Weerd, V; Foekens, JA; Kloosterboer, HJ; Martens, JW; Sieuwerts, AM; van Galen, A; Zhang, H	1
Hirschberg, AL; Lundström, E; Söderqvist, G	1
Aravantinos, L; Augoulea, A; Creatsa, M; Kyroudi, A; Lambrinoudaki, I; Panoulis, C; Politi, E; Rizos, D; Sergentanis, TN; Sioulas, VD	1
Dahm, AE; Eilertsen, AL; Goeman, J; Kierulf, P; Mowinckel, MC; Olstad, OK; Ovstebø, R; Sandset, PM; Skretting, G	1
Godsland, IF; Manassiev, N; Proudler, AJ; Stevenson, JC; Whitehead, MI	1
Di Luca, M; Ferrero, S; Leone Roberti Maggiore, U; Remorgida, V; Scala, C; Venturini, PL	1
Andrade, AT; Brandão, M; Castro, IQ; Guerra, Mde O; Polisseni, AF; Polisseni, F; Ribeiro, LC	1
Cunha, EP; Fernandes, CE; Mader, AM; Pinhal, MA; Pompei, LM; Silva, VF; Silveira, ER; Steiner, ML; Theodoro, TR	1
Cunha, EP; Fernandes, CE; Mader, AM; Petri, G; Pinhal, MA; Pompei, LM; Steiner, ML; Theodoro, TR	1
Graff-Iversen, S; Hofvind, S; Román, M; Sakshaug, S; Ursin, G; Vangen, S; Weiderpass, E	1
Hadji, P; Hars, O; Kalder, M; Kauka, A; Kyvernitakis, I	1

Reviews

2 review(s) available for norethindrone and tibolone

Article	Year
[Tibolone]. Presse medicale (Paris, France : 1983), 2002, Sep-07, Volume: 31, Issue:28 Topics: Adult; Aged; Animals; Blood Coagulation; Breast; Cardiovascular Diseases; Controlled Clinical Trials as Topic; Double-Blind Method; Endometrium; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Hysterectomy; Lipid Metabolism; Lipids; Medrogestone; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Osteoporosis, Postmenopausal; Ovariectomy; Placebos; Postmenopause; Progesterone Congeners; Prospective Studies; Rabbits; Rats; Risk Factors; Surveys and Questionnaires; Time Factors	2002
Can 19-nortestosterone derivatives be aromatized in the liver of adult humans? Are there clinical implications? Climacteric : the journal of the International Menopause Society, 2007, Volume: 10, Issue:4 Topics: Androgens; Aromatase; Breast Diseases; Cardiovascular Diseases; Ethinyl Estradiol; Female; Humans; Hyperlipoproteinemias; Liver; Nandrolone; Norethindrone; Norethynodrel; Norpregnenes; Uterine Diseases	2007

Article

Year

[Tibolone].

Presse medicale (Paris, France : 1983), 2002, Sep-07, Volume: 31, Issue:28

Topics: Adult; Aged; Animals; Blood Coagulation; Breast; Cardiovascular Diseases; Controlled Clinical Trials as Topic; Double-Blind Method; Endometrium; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Hysterectomy; Lipid Metabolism; Lipids; Medrogestone; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Osteoporosis, Postmenopausal; Ovariectomy; Placebos; Postmenopause; Progesterone Congeners; Prospective Studies; Rabbits; Rats; Risk Factors; Surveys and Questionnaires; Time Factors

2002

Can 19-nortestosterone derivatives be aromatized in the liver of adult humans? Are there clinical implications?

Climacteric : the journal of the International Menopause Society, 2007, Volume: 10, Issue:4

Topics: Androgens; Aromatase; Breast Diseases; Cardiovascular Diseases; Ethinyl Estradiol; Female; Humans; Hyperlipoproteinemias; Liver; Nandrolone; Norethindrone; Norethynodrel; Norpregnenes; Uterine Diseases

2007

Trials

45 trial(s) available for norethindrone and tibolone

Article	Year
Benefits and risks of different hormonal replacement therapies in post-menopausal women. Maturitas, 1986, Volume: 8, Issue:4 Topics: Adult; Cholesterol; Climacteric; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Endometrium; Estradiol; Estriol; Estrogens, Conjugated (USP); Female; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Menopause; Middle Aged; Norethindrone; Norpregnenes	1986
Effect on sexual life--a comparison between tibolone and a continuous estradiol-norethisterone acetate regimen. Maturitas, 1997, Volume: 26, Issue:1 Topics: Anabolic Agents; Climacteric; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Libido; Middle Aged; Norethindrone; Norpregnenes; Sexual Behavior	1997
A double-blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms. British journal of obstetrics and gynaecology, 1998, Volume: 105, Issue:8 Topics: Anabolic Agents; Double-Blind Method; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norethindrone; Norpregnenes; Postmenopause; Progesterone Congeners; Sexual Behavior; Sweating; Uterine Hemorrhage; Vaginal Diseases	1998
A prospective randomized controlled study comparing the morphological and biochemical responses of the endometrium to two different forms of 'period-free' hormone replacement therapy. Human reproduction (Oxford, England), 1998, Volume: 13, Issue:8 Topics: CA-125 Antigen; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Glycodelin; Glycoproteins; Humans; Menstruation; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Pregnancy Proteins; Prospective Studies	1998
Continuous combined hormone replacement therapy compared with tibolone. Obstetrics and gynecology, 1999, Volume: 93, Issue:2 Topics: Climacteric; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Lipoproteins; Menstruation; Middle Aged; Minor Histocompatibility Loci; Norethindrone; Norpregnenes; Progesterone Congeners	1999
Impact on uterine bleeding and endometrial thickness: tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy. Menopause (New York, N.Y.), 1999,Winter, Volume: 6, Issue:4 Topics: Aged; Anabolic Agents; Double-Blind Method; Drug Combinations; Endometrial Hyperplasia; Endosonography; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Incidence; Middle Aged; Norethindrone; Norpregnenes; Prospective Studies; Tablets; Uterine Hemorrhage; Vagina	1999
Effects of tibolone and continuous combined hormone replacement therapy on parameters in the clotting cascade: a multicenter, double-blind, randomized study. Fertility and sterility, 2000, Volume: 74, Issue:1 Topics: Aged; Blood Coagulation; Blood Coagulation Tests; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Fibrinolysis; Hemostasis; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Thromboembolism	2000
Resistance of pelvic arteries and plasma lipids in postmenopausal women: comparative study of tibolone and continuous combined estradiol and norethindrone acetate replacement therapy. American journal of obstetrics and gynecology, 2000, Volume: 183, Issue:3 Topics: Anabolic Agents; Arteries; Estradiol; Female; Humans; Iliac Artery; Lipids; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Pelvis; Postmenopause; Pulsatile Flow; Ultrasonography, Doppler, Color; Uterus; Vascular Resistance	2000
The effect of tibolone versus continuous combined norethisterone acetate and oestradiol on memory, libido and mood of postmenopausal women: a pilot study. Maturitas, 2000, Oct-31, Volume: 36, Issue:3 Topics: Affect; Anabolic Agents; Body Mass Index; Drug Combinations; Estradiol; Female; Hormone Replacement Therapy; Humans; Libido; Memory; Middle Aged; Norethindrone; Norpregnenes; Patient Compliance; Pilot Projects; Postmenopause	2000
Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy. Fertility and sterility, 2001, Volume: 75, Issue:3 Topics: Androgens; Androstenedione; Dehydroepiandrosterone Sulfate; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone	2001
Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density. American journal of obstetrics and gynecology, 2002, Volume: 186, Issue:4 Topics: Biopsy, Needle; Breast; Double-Blind Method; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Humans; Mammography; Norethindrone; Norethindrone Acetate; Norpregnenes; Placebos; Postmenopause; Prospective Studies	2002
Randomized, double-masked, 2-year comparison of tibolone with 17beta-estradiol and norethindrone acetate in preventing postmenopausal bone loss. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2002, Volume: 13, Issue:3 Topics: Androgen Antagonists; Bone Density; Breast; Calcium; Double-Blind Method; Estradiol; Female; Humans; Lumbar Vertebrae; Middle Aged; Norethindrone; Norpregnenes; Osteoporosis, Postmenopausal; Pain; Progesterone Congeners; Statistics, Nonparametric; Uterine Hemorrhage	2002
Impact of different hormone replacement therapy regimens on the size of myoma uteri in postmenopausal period: tibolone versus transdermal hormonal replacement system. Maturitas, 2002, Jul-25, Volume: 42, Issue:3 Topics: Administration, Cutaneous; Aged; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Polyps; Postmenopause; Progesterone Congeners; Ultrasonography; Uterine Hemorrhage; Uterine Neoplasms	2002
Effects of tibolone and combined 17beta-estradiol and norethisterone acetate on serum C-reactive protein in healthy post-menopausal women: a randomized trial. Human reproduction (Oxford, England), 2002, Volume: 17, Issue:10 Topics: Adult; C-Reactive Protein; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Weight Gain	2002
Haemostatic risk factors in healthy postmenopausal women taking hormone replacement therapy. Maturitas, 2002, Oct-25, Volume: 43, Issue:2 Topics: Estradiol; Female; Hemostasis; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Risk Factors; Time Factors	2002
The short-term effects of different regimens of hormone replacement therapy on left ventricular structure and performance in healthy postmenopausal women. A prospective, controlled echocardiographic study. Gynecologic and obstetric investigation, 2003, Volume: 55, Issue:3 Topics: Administration, Cutaneous; Cardiac Output; Estradiol; Estrogen Replacement Therapy; Female; Heart Ventricles; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Prospective Studies; Stroke Volume; Systole; Ultrasonography; Ventricular Function, Left	2003
Changes in body composition during post-menopausal hormone therapy: a 2 year prospective study. Human reproduction (Oxford, England), 2003, Volume: 18, Issue:8 Topics: Adipose Tissue; Alkaline Phosphatase; Body Composition; Bone and Bones; Bone Density; Collagen; Collagen Type I; Estradiol; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Osteocalcin; Peptides; Prospective Studies; Thinness	2003
The effects of hormone replacement therapy type on pulmonary functions in postmenopausal women. Maturitas, 2003, Nov-20, Volume: 46, Issue:3 Topics: Adult; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Forced Expiratory Volume; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Prospective Studies; Random Allocation; Vital Capacity	2003
Effects of low-dose 17-beta-estradiol plus norethisterone acetate and tibolone on fasting plasma homocysteine levels in postmenopausal women. Acta obstetricia et gynecologica Scandinavica, 2003, Volume: 82, Issue:12 Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Fasting; Female; Homocysteine; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Probability; Reference Values; Sensitivity and Specificity	2003
A comparative study of breast cell proliferation during hormone replacement therapy: effects of tibolon and continuous combined estrogen-progestogen treatment. Climacteric : the journal of the International Menopause Society, 2004, Volume: 7, Issue:1 Topics: Aged; Antibodies, Monoclonal; Biopsy, Needle; Breast; Cell Division; Contraceptives, Oral, Synthetic; Double-Blind Method; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Ki-67 Antigen; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Prospective Studies	2004
Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2004, Volume: 18, Issue:5 Topics: Adult; Aged; Apolipoprotein A-I; Apolipoproteins; Apolipoproteins B; Cholesterol; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Greece; Humans; Lipids; Lipoprotein(a); Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Triglycerides	2004
The role of hormone replacement therapy in endometrial polyp formation. Maturitas, 2005, Mar-14, Volume: 50, Issue:3 Topics: Adult; Contraceptives, Oral, Synthetic; Double-Blind Method; Endometrium; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Hysteroscopy; Medroxyprogesterone; Menopause; Middle Aged; Norethindrone; Norpregnenes; Obesity; Polyps; Prospective Studies; Recurrence; Regression Analysis	2005
Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels--an association with mammographic density. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2005, Volume: 20, Issue:2 Topics: Aged; Breast; Estradiol; Estrogen Replacement Therapy; Female; Gonadal Steroid Hormones; Humans; Insulin-Like Growth Factor I; Mammography; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Testosterone	2005
Evaluation of mammographic density and (99m)Tc-sestamibi scintimammographic uptake in postmenopausal women on hormone replacement therapy. Maturitas, 2006, Jan-10, Volume: 53, Issue:1 Topics: Breast; Chi-Square Distribution; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Mammography; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Prospective Studies; Radionuclide Imaging	2006
Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women. Fertility and sterility, 2005, Volume: 84, Issue:2 Topics: Adult; Aged; Blood Coagulation Factors; Blood Glucose; Body Mass Index; Bone Density; Contraceptives, Oral, Synthetic; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipids; Medroxyprogesterone; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Obesity; Overweight; Pharmaceutical Preparations; Postmenopause	2005
Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation. Maturitas, 2006, Oct-20, Volume: 55, Issue:3 Topics: Antineoplastic Agents, Hormonal; Blood Coagulation; Blood Coagulation Tests; Bone Density Conservation Agents; Drug Therapy, Combination; Estradiol; Female; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Raloxifene Hydrochloride; Thromboembolism	2006
Tibolone and estradiol plus norethisterone acetate similarly influence endothelium-dependent vasodilatation in healthy postmenopausal women. Fertility and sterility, 2006, Volume: 86, Issue:2 Topics: Brachial Artery; Drug Combinations; Endothelium, Vascular; Estradiol; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Reference Values; Regional Blood Flow; Vasodilation	2006
Circulating chemoattractants RANTES, negatively related to endogenous androgens, and MCP-1 are differentially suppressed by hormone therapy and raloxifene. Atherosclerosis, 2007, Volume: 193, Issue:1 Topics: Adult; Androgens; Atherosclerosis; Biomarkers; Cardiovascular System; Chemokine CCL2; Chemokine CCL5; Chemotaxis; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators	2007
Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis. Thrombosis research, 2007, Volume: 120, Issue:3 Topics: Administration, Oral; Aged; Blood Coagulation; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Estrogen Receptor Modulators; Female; Fibrinolysis; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Retrospective Studies; Time Factors	2007
Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system. Thrombosis and haemostasis, 2007, Volume: 97, Issue:6 Topics: Activated Protein C Resistance; Administration, Oral; Blood Coagulation; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Protein C; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tablets; Thromboembolism; Treatment Outcome; Venous Thrombosis	2007
The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women. Climacteric : the journal of the International Menopause Society, 2007, Volume: 10, Issue:5 Topics: Analysis of Variance; Blood Coagulation; Blood Coagulation Factors; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Estradiol Congeners; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrinolysis; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Thromboembolism; Venous Thrombosis	2007
Tibolone and low-dose continuous combined hormone treatment: vaginal bleeding pattern, efficacy and tolerability. BJOG : an international journal of obstetrics and gynaecology, 2007, Volume: 114, Issue:12 Topics: Aged; Contraceptives, Oral, Synthetic; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Hot Flashes; Humans; Metrorrhagia; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes	2007
Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene. Maturitas, 2008, Jan-20, Volume: 59, Issue:1 Topics: Adult; Body Mass Index; Contraceptives, Oral, Synthetic; Estradiol; Estrogen Receptor Modulators; Estrogens; Estrogens, Conjugated (USP); Fas Ligand Protein; Female; Follicle Stimulating Hormone; Ghrelin; Hormone Replacement Therapy; Humans; Insulin; Leptin; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Raloxifene Hydrochloride; Sex Hormone-Binding Globulin	2008
Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial. The journal of sexual medicine, 2008, Volume: 5, Issue:3 Topics: Administration, Cutaneous; Adult; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Libido; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Sexual Dysfunction, Physiological; Stress, Psychological	2008
Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method. BJOG : an international journal of obstetrics and gynaecology, 2008, Volume: 115, Issue:6 Topics: Administration, Oral; Aged; Breast; Contraceptives, Oral, Synthetic; Drug Combinations; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Hormone Replacement Therapy; Humans; Mammography; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Organ Size; Postmenopause; Raloxifene Hydrochloride	2008
A comparison of hormone therapies on the urinary excretion of prostacyclin and thromboxane A2. Climacteric : the journal of the International Menopause Society, 2008, Volume: 11, Issue:6 Topics: Cardiovascular Diseases; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Epoprostenol; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Raloxifene Hydrochloride; Thromboxane A2	2008
Improved bleeding profile and tolerability of tibolone versus transdermal E2/NETA treatment in postmenopausal women with female sexual dysfunction. Climacteric : the journal of the International Menopause Society, 2009, Volume: 12, Issue:2 Topics: Administration, Cutaneous; Aged; Breast; Double-Blind Method; Estradiol; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Pain; Postmenopause; Sexual Dysfunction, Physiological; Uterine Hemorrhage	2009
The effect of hormone therapy and tibolone on serum CD40L and ADAM-8 in healthy post-menopausal women. Journal of endocrinological investigation, 2010, Volume: 33, Issue:10 Topics: ADAM Proteins; Adult; Androgen Antagonists; Androstenes; CD40 Ligand; Estradiol; Estrogen Replacement Therapy; Female; Health; Humans; Membrane Proteins; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Progesterone Congeners	2010
Hormone replacement therapy dependent changes in breast cancer-related gene expression in breast tissue of healthy postmenopausal women. Molecular oncology, 2011, Volume: 5, Issue:6 Topics: Breast; Breast Neoplasms; Estradiol; Estrogen Receptor Modulators; Female; Gene Expression Regulation, Neoplastic; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Prospective Studies; Risk Factors	2011
Digitized assessment of mammographic breast density--effects of continuous combined hormone therapy, tibolone and black cohosh compared to placebo. Maturitas, 2011, Volume: 70, Issue:4 Topics: Breast; Cimicifuga; Contraceptives, Oral, Synthetic; Densitometry; Double-Blind Method; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Hormone Replacement Therapy; Humans; Mammography; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Plant Preparations; Postmenopause; Radiographic Image Interpretation, Computer-Assisted; Statistics, Nonparametric	2011
A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women. Thrombosis research, 2012, Volume: 130, Issue:1 Topics: Aged; Drug Combinations; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Gene Expression Regulation; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norpregnenes; Postmenopause; Raloxifene Hydrochloride	2012
Effects of tibolone or continuous combined oestradiol/norethisterone acetate on glucose and insulin metabolism. Clinical endocrinology, 2013, Volume: 78, Issue:2 Topics: Aged; Blood Glucose; C-Peptide; Contraceptives, Oral, Synthetic; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Glucose; Humans; Insulin; Insulin Resistance; Middle Aged; Norethindrone; Norpregnenes	2013
Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies. Archives of gynecology and obstetrics, 2013, Volume: 287, Issue:3 Topics: Adult; Aromatase Inhibitors; Calcium; Cholecalciferol; Contraceptives, Oral, Sequential; Contraceptives, Oral, Synthetic; Desogestrel; Endometriosis; Estrogen Receptor Modulators; Female; Humans; Image Processing, Computer-Assisted; Letrozole; Nitriles; Norethindrone; Norethindrone Acetate; Norpregnenes; Prospective Studies; Rectal Diseases; Treatment Outcome; Triazoles; Triptorelin Pamoate; Ultrasonography; Vaginal Diseases; Vitamins	2013
Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study. Maturitas, 2013, Volume: 74, Issue:2 Topics: Affect; Calcium Carbonate; Cholecalciferol; Contraceptives, Oral, Synthetic; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Quality of Life; Sexual Behavior; Statistics, Nonparametric; Surveys and Questionnaires; Vitamins	2013
Comparison of combined low-dose hormone therapy vs. tibolone in the prevention of bone loss. Climacteric : the journal of the International Menopause Society, 2016, Volume: 19, Issue:5 Topics: Absorptiometry, Photon; Bone Density; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norpregnenes; Osteoporosis, Postmenopausal; Prospective Studies; Uterine Hemorrhage	2016

Other Studies

20 other study(ies) available for norethindrone and tibolone

Article	Year
Quantitative relationships between steroid structure and binding to putative progesterone receptors. Journal of medicinal chemistry, 1977, Volume: 20, Issue:9 Topics: Androstenes; Animals; Guinea Pigs; Humans; Hydroxyprogesterones; Protein Binding; Rabbits; Receptors, Progesterone; Sheep; Steroids; Structure-Activity Relationship	1977
Regression of endometrial thickness in combination with reduced withdrawal bleeding as a progestational effect of tibolone in postmenopausal women on oestrogen replacement therapy. Maturitas, 1995, Volume: 21, Issue:2 Topics: Adult; Aged; Endometrium; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norpregnenes; Postmenopause; Progestins; Uterine Hemorrhage	1995
Anabolic effects of progestogens in bone remodelling. Sbornik lekarsky, 1995, Volume: 96, Issue:4 Topics: Alkaline Phosphatase; Bone and Bones; Bone Density; Bone Remodeling; Estradiol; Female; Follow-Up Studies; Humans; Hydroxyproline; Norethindrone; Norpregnenes; Osteoporosis; Ovariectomy; Progestins; Prospective Studies	1995
Serum vascular endothelial growth factor concentrations in postmenopausal women: the effect of hormone replacement therapy. Fertility and sterility, 2000, Volume: 73, Issue:1 Topics: Aged; Cross-Sectional Studies; Endothelial Growth Factors; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hysterectomy; Levonorgestrel; Lymphokines; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2000
Economic impact of tibolone compared with continuous-combined hormone replacement therapy. In the management of postmenopausal women with climacteric symptoms in the UK. PharmacoEconomics, 2000, Volume: 18, Issue:5 Topics: Anabolic Agents; Drug Costs; Estradiol; Female; Hormone Replacement Therapy; Humans; Markov Chains; Models, Economic; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; United Kingdom	2000
Mammographic density changes during different postmenopausal hormone replacement therapies. Fertility and sterility, 2001, Volume: 76, Issue:3 Topics: Cyproterone Acetate; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Mammography; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Progesterone Congeners; Retrospective Studies; Time Factors	2001
[Effect of tibolone on vascular markers of human female coronary arteries - comparison with estradiol/norethisterone]. Zentralblatt fur Gynakologie, 2001, Volume: 123, Issue:11 Topics: Cell Division; Coronary Vessels; Culture Techniques; Dose-Response Relationship, Drug; Endothelium, Vascular; Estradiol; Estrogen Replacement Therapy; Female; Humans; Muscle, Smooth, Vascular; Norethindrone; Norpregnenes; Vascular Resistance	2001
Tibolone versus 17beta-estradiol/norethisterone: effects on the proliferation of human breast cancer cells. European journal of gynaecological oncology, 2002, Volume: 23, Issue:2 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Division; Cell Line; Estradiol; Female; Humans; Norethindrone; Norpregnenes; Progesterone Congeners; Tumor Cells, Cultured	2002
Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene. Maturitas, 2005, Apr-11, Volume: 50, Issue:4 Topics: Adult; Aged; Androgens; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Insulin; Insulin Resistance; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Sex Hormone-Binding Globulin; Testosterone	2005
Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2005, Volume: 20, Issue:3 Topics: Administration, Cutaneous; Adrenal Glands; Aging; Dehydroepiandrosterone; Estradiol; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Hydrocortisone; Hysterectomy; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Ovariectomy; Postmenopause; Pregnanolone; Progesterone; Progestins	2005
Apoptosis and proliferation in breast cancer cells, cultured in vitro: effects of SERMs. Climacteric : the journal of the International Menopause Society, 2005, Volume: 8, Issue:3 Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Contraceptive Agents, Female; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Humans; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Norpregnenes; Progesterone; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Tumor Cells, Cultured	2005
Lack of aromatisation of the 3-keto-4-ene metabolite of tibolone to an estrogenic derivative. Steroids, 2006, Volume: 71, Issue:7 Topics: Aromatase; Aromatase Inhibitors; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Estradiol; Estrogen Replacement Therapy; Estrogens; Ethinyl Estradiol; Letrozole; Nitriles; Norethindrone; Norpregnenes; Triazoles; Tumor Cells, Cultured	2006
Quality of life and psychological symptoms in Greek postmenopausal women: association with hormone therapy. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2006, Volume: 22, Issue:12 Topics: Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Greece; Health Surveys; Humans; Life Style; Medroxyprogesterone; Mental Health; Middle Aged; Norethindrone; Norpregnenes; Postmenopause; Prospective Studies; Quality of Life; Social Behavior	2006
Tibolone and its delta-4, 7alpha-methyl norethisterone metabolite are reversible inhibitors of human aromatase. The Journal of steroid biochemistry and molecular biology, 2007, Volume: 104, Issue:3-5 Topics: Aromatase; Aromatase Inhibitors; Dose-Response Relationship, Drug; Estrone; Humans; Models, Biological; Norethindrone; Norpregnenes; Time Factors; Tumor Cells, Cultured	2007
In vitro effects of tibolone and its metabolites on human vascular coronary cells. Maturitas, 2007, Sep-20, Volume: 58, Issue:1 Topics: Biomarkers; Cells, Cultured; Coronary Vessels; E-Selectin; Endothelins; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Epoprostenol; Estradiol; Female; Humans; Intercellular Adhesion Molecule-1; Matrix Metalloproteinase 1; Medroxyprogesterone Acetate; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Norethindrone; Norpregnenes; Plasminogen Activator Inhibitor 1; Vascular Resistance	2007
Postmenopausal hormone therapy with estradiol and norethisterone acetate and mammographic density: findings from a cross-sectional study among Norwegian women. Climacteric : the journal of the International Menopause Society, 2009, Volume: 12, Issue:3 Topics: Breast; Contraceptives, Oral, Synthetic; Cross-Sectional Studies; Dose-Response Relationship, Drug; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Humans; Mammography; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Norway; Postmenopause	2009
Does hormone therapy, tibolone or raloxifene modify VEGF expression in cervical epithelial cells? Climacteric : the journal of the International Menopause Society, 2012, Volume: 15, Issue:2 Topics: Aged; Androstenedione; Cervix Uteri; Contraceptives, Oral, Synthetic; Cross-Sectional Studies; Epithelial Cells; Estradiol; Estrogen Antagonists; Estrogen Receptor Modulators; Estrogens; Female; Humans; Metaplasia; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Papanicolaou Test; Postmenopause; Raloxifene Hydrochloride; Statistics, Nonparametric; Vaginal Smears; Vascular Endothelial Growth Factor A	2012
Is expression of rat breast matrix components influenced by estrogen, progestins and tibolone? Climacteric : the journal of the International Menopause Society, 2015, Volume: 18, Issue:4 Topics: Animals; Biomarkers; Breast; Cell Proliferation; Drug Combinations; Dydrogesterone; Estradiol; Estrogen Receptor Modulators; Estrogens; Extracellular Matrix; Female; Glucuronidase; Heparan Sulfate Proteoglycans; Immunohistochemistry; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Medroxyprogesterone Acetate; Norethindrone; Norpregnenes; Progestins; Proliferating Cell Nuclear Antigen; Random Allocation; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction	2015
Effects of estradiol, progestogens, and of tibolone on breast proliferation and apoptosis. Climacteric : the journal of the International Menopause Society, 2015, Volume: 18, Issue:4 Topics: Animals; Apoptosis; Breast; Cell Proliferation; Drug Combinations; Dydrogesterone; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Medroxyprogesterone Acetate; Norethindrone; Norpregnenes; Progestins; Random Allocation; Rats; Rats, Wistar	2015
Postmenopausal hormone therapy and the risk of breast cancer in Norway. International journal of cancer, 2016, Feb-01, Volume: 138, Issue:3 Topics: Aged; Breast Neoplasms; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Middle Aged; Norethindrone; Norpregnenes; Risk	2016